Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-049406
Filing Date
2004-03-25
Accepted
2004-03-25 17:25:59
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE PERIOD ENDED DECEMBER 31, 2003 d10k.htm 10-K 774718
3 AMENDMENT TO CONSULTING AGREEMENT, dex105.htm EX-10.5 6032
4 AMENDMENT TO EMPLOYMENT AGREEMENT, dex1010.htm EX-10.10 6214
5 SUBSIDIARIES OF IVAX DIAGNOSTICS dex211.htm EX-21.1 2192
6 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1476
7 INFORMATION REGARDING CONSENT dex232.htm EX-23.2 3139
8 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8476
9 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8464
10 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4176
11 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4164
  Complete submission text file 0001193125-04-049406.txt   821798
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 90802 5624917180
IVAX DIAGNOSTICS INC (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14798 | Film No.: 04690505
SIC: 2834 Pharmaceutical Preparations